Pharmacy Articles

Pharmacy

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Zhao RK et al. - In these healthy Chinese subjects, AUC and Cmax increased proportionally with the dose, whereas t1/2 was independent of the dose. Linear PK properties were found at doses of 30 to 90 mg. No statistically significant differences were observed between the PK parameters for the subjects in the multiple-dose phase (t1/2, CL, Vd) and those for subjects in the single-dose phase. The AUC and Cmax were greater after administration of multiple doses than after administration of a single dose, suggesting du-loxetine accumulation with multiple-dose administration of 30 mg.

Today in Pharmacokinetics...keeping you current

Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age
The Pediatric Infectious Disease Journal, 12/15/09

Evaluating pharmacokinetics and pharmacodynamics of intravenous busulfan in pediatric patients receiving bone marrow transplantation
Pediatric Transplantation, 12/15/09

'Party pill' drugs - BZP and TFMPP
New Zealand Medical Journal, 12/14/09